Publication Name	World Journal of Hepatology
Manuscript ID	10888
Country	Japan

Received	2014-04-24 20:35
Peer-Review Started	2014-04-24 22:40
First Decision by Editorial Office Director
Return for Revision	2014-05-20 20:49
Revised	2014-05-21 12:22
Publication Fee Transferred
Second Decision by Editor	2014-08-29 19:05
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-08-29 19:15
Articles in Press	2014-08-29 19:16
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-30 16:15
Publish the Manuscript Online	2014-10-19 20:39

ISSN	1948-5182 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Nobuhisa Akamatsu, Yasuhiko Sugawara and Norihiro Kokudo
Funding Agency and Grant Number
Corresponding Author	Yasuhiko Sugawara, MD, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. yasusuga-tky@umin.ac.jp
Key Words	Deceased donor liver transplantation; Hepatocellular carcinoma; Living donors; Living-donor liver transplantation; Recurrence
Core Tip	The current opinions and clinical reports regarding differences in the recurrence of hepatocellular carcinoma (HCC) between living donor liver transplantation (LDLT) and deceased donor liver transplantation (DDLT) were reviewed. In the absence of a prospective study regarding the use of LDLT vs DDLT for HCC patients, only with some retrospective studies with conflicting results, there is no evidence to support the higher HCC recurrence after LDLT than DDLT, and LDLT remains a reasonable treatment option for HCC patients with cirrhosis.
Publish Date	2014-10-19 20:39
Citation	Akamatsu N, Sugawara Y, Kokudo N. Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma. World J Hepatol 2014; 6(9): 626-631
URL	http://www.wjgnet.com/1948-5182/full/v6/i9/626.htm
DOI	http://dx.doi.org/10.4254/wjh.v6.i9.626

Full Article (PDF)	WJH-6-626.pdf
Full Article (Word)	WJH-6-626.doc
Manuscript File	10888-edited(download).docx
Answering Reviewers	10888-Answering reviewers.pdf
Copyright License Agreement	10888-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20140424125409.docx
Peer-review Report	10888-Peer review(s).pdf
Scientific Misconduct Check	10888-CrossCheck.jpg
Scientific Editor Work List	10888-Scientific editor work list.pdf